S&P 500
5,933.08
-0.1%
-7.38
DJI
42,370.20
-0.7%
-307.04
NASDAQ
$19,213.39
+0.4%
+$70.67
Bitcoin
108,757.00
+3.9%
+4,080.37
AAPL
$206.97
+0.1%
+$0.11
AMZN
$203.15
-0.5%
-$0.92
GOOG
$173.83
+5.1%
+$8.51
META
$645.07
+1.3%
+$7.97
MSFT
$457.13
-0.2%
-$1.04
NVDA
$135.95
+1.2%
+$1.57
TSLA
$345.78
+0.6%
+$1.96
Zenosense (OTC: ZENO)
Some price data may be temporarily unavailable.
Zenosense Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Zenosense Company Info
Zenosense, Inc. engages in developing medical devices for the diagnosis of heart attack and cardiac-related illnesses. It includes the detection of the Methicillin-resistant Staphylococcus aureus. The firm uses Acute Myocardial Infarction, and MIDS Cardiac technologies. The company was founded on August 11, 2008 and is headquartered in New Haven, CT.
News & Analysis
No articles found.
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.